Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 32 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11013740

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

    granted
  2. US 11008304

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  3. US 11008325

    Inhibitors of cancer invasion, attachment, and/or metastasis

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted May 18, 2021 · Expires May 13, 2041

    granted
  4. US 11007183

    Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  5. US 11007184

    Cancer treatments using combinations of type 2 MEK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  6. US 11008305

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 18, 2021 · Expires May 13, 2041

    granted
  7. US 11000513

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  8. US 11001578

    N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted
  9. US 11001592

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  10. US 11001613

    TFPI inhibitors and methods of use

    Takeda Pharmaceutical Company Limited · Granted May 11, 2021 · Expires May 6, 2041

    granted
  11. US 10995100

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  12. US 10995061

    SPAK kinase inhibitors as neuroprotective agents

    United States Government as represented by the Department of Veterans Affairs · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  13. US 10993948

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  14. US 10993936

    Method of treating one or more symptoms of pulmonary fibrosis by administering inhibitors of nicotinamide phosphoribotransferase

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  15. US 10995087

    Crystal form of URAT1 inhibitor, and preparation method therefor

    Medshine Discovery Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  16. US 10993941

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  17. US 10995089

    Zaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  18. US 10988450

    3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  19. US 10987354

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  20. US 10988441

    Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

    Valo Early Discovery, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  21. US 10988458

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  22. US 10988465

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  23. US 10988470

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  24. US 10988477

    GCN2 inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted